Adrian Richter

Dr. Adrian Richter

Department of Pharmaceutical Chemistry, Martin-Luther-Universitaet Halle-Wittenberg, Halle, Germany
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
LMLea Mann
Lea Mann
UGUday S. Ganapathy
Uday S. Ganapathy
RARana Abdelaziz
Rana Abdelaziz
MLMarkus Lang
Markus Lang
MZMatthew D. Zimmerman
Matthew D. Zimmerman
ARAdrian Richter
Adrian Richter
Infections with nontuberculous mycobacteria are an increasing health problem, and only a few new drug classes show activity against these multidrug-resistant bacteria. Due to insufficient therapy options, the development of new drug leads is necessary and should be advanced. The lead compound MMV688845, a substance active against M. abscessus complex, was characterized in depth. In various assays, it showed activity against M. abscessus , synergy with other antibiotics, and bactericidal effects.

31 March 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MLMarkus Lang
Markus Lang
UGUday S. Ganapathy
Uday S. Ganapathy
LMLea Mann
Lea Mann
RARana Abdelaziz
Rana Abdelaziz
RSRüdiger W. Seidel
Rüdiger W. Seidel
ARAdrian Richter
Adrian Richter

23 December 2021 in ChemMedChem
Verified
Journal Article
Open access
PDF file
ARAdrian Richter
Adrian Richter
GNGagandeep Narula
Gagandeep Narula
IRInes Rudolph
Ines Rudolph
RSRüdiger W. Seidel
Rüdiger W. Seidel
CWChristoph Wagner
Christoph Wagner
PIPeter Imming
Peter Imming
8‐Nitrobenzothiazinones (BTZs) are a promising class of antimycobacterial agents currently under investigation in clinical trials. Starting from thiourea derivatives, a new synthetic pathway to BTZs was established. It allows the formation of the thiazinone ring system in one synthetic step and is applicable for preparation of a wide variety of BTZ analogues. The synthetic procedure furthermore facilitates the replacement of the sulphur atom in the thiazinone ring system by oxygen or nitrogen to afford the analogous benzoxazinone and quinazolinone systems. 36 BTZ analogues were prepared and tested in luminescence‐based assays for in vitro activity against Mycobacterium tuberculosis (Mtb) using the microdilution broth method and a high‐throughput macrophage infection assay.

13 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Betelhem Sirak TatekBetelhem Sirak Tatek
Betelhem Sirak Tatek
LMLea Mann
Lea Mann
ARAdrian Richter
Adrian Richter
KAKaleab Asres
Kaleab Asres
PIPeter Imming
Peter Imming
The leaves of Ranunculus multifidus Forsk. are traditionally used for the treatment of malaria in several African countries. In the present study, 80% methanol (RM-M) and hydrodistilled (RM-H) extracts of fresh leaves from R. multifidus and its major constituent anemonin were tested for their in vivo antimalarial activity against Plasmodium berghei in mice. Anemonin was also tested for its in vitro antimycobacterial activity against Mycobacterium smegmatis and M. abscessus in a microbroth dilution assay, and bacterial growth was analyzed by OD measurement. The isolation of anemonin from RM-H was carried out using preparative thin layer chromatography (PTLC). The chemical structures of anemonin and its hydrolysis product were elucidated using spectroscopic methods (HR–MS; 1D and 2D-NMR). Results of the study revealed that both RM-M and RM-H were active against P. berghei in mice, although the latter demonstrated superior activity (p < 0.001), as compared to the former. At a dose of 35.00 mg/kg/day, RM-H demonstrated a chemosuppression value of 70% in a 4-day suppressive test. In a 4-day suppressive, Rane’s and prophylactic antimalarial tests, anemonin showed median effective doses (ED50s) of 2.17, 2.78 and 2.70 μM, respectively. However, anemonin did not inhibit the growth of M. smegmatis and M. abscessus.

25 July 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ARAdrian Richter
Adrian Richter
RSRüdiger W. Seidel
Rüdiger W. Seidel
RGRichard Goddard
Richard Goddard
TETamira Eckhardt
Tamira Eckhardt
CLChristoph Lehmann
Christoph Lehmann
PIPeter Imming
Peter Imming

28 February 2022 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ABAndreas Beuchel
Andreas Beuchel
DRDina Robaa
Dina Robaa
DNDereje A. Negatu
Dereje A. Negatu
AMAbdeldjalil Madani
Abdeldjalil Madani
Nadine AlvarezNadine Alvarez
Nadine Alvarez
PIPeter Imming
Peter Imming